H.B. Fuller has added R. Jeffrey Bailly to its board of directors, effective immediately, and Ruth Kimmelshue is stepping down after nine years on the board.
The appointment comes as the company continues to push toward a stated goal of more than 20% adjusted EBITDA margin. Management said Bailly’s background in medical end markets and manufacturing transformation fits that effort.
Bailly spent 31 years at UFP Technologies, serving as CEO from 1995 to 2026. During that period, UFP’s revenue increased about 20-fold, while profitability and market capitalization rose more than 150-fold. Over the final five years of his tenure, UFP’s share price climbed roughly 300%.
Under Bailly’s leadership, UFP completed more than 20 acquisitions, including the 2018 purchase of Dielectrics, which helped accelerate the company’s move deeper into medical technology. Before becoming CEO, he held several operating roles at UFP, including vice president of operations, general manager of Northeast operations, and division manager. He also previously worked at Coopers & Lybrand.
H.B. Fuller said 2025 revenue was $3.5 billion and that it has more than 7,100 employees serving customers in more than 30 market segments across 150 countries.
Kimmelshue’s departure removes a director who had been on the board for nearly a decade, as the company enters what it described as a new phase of transformation. The market has reacted to these announcements by moving the company's shares 0.12% to a price of $50.06. Check out the company's full 8-K submission here.
